FR3074684B1 - NEW ANTI-STRESS PROCESS FOR THE SKIN INDUCED BY EXPOSURE TO BLUE LIGHT - Google Patents

NEW ANTI-STRESS PROCESS FOR THE SKIN INDUCED BY EXPOSURE TO BLUE LIGHT Download PDF

Info

Publication number
FR3074684B1
FR3074684B1 FR1761824A FR1761824A FR3074684B1 FR 3074684 B1 FR3074684 B1 FR 3074684B1 FR 1761824 A FR1761824 A FR 1761824A FR 1761824 A FR1761824 A FR 1761824A FR 3074684 B1 FR3074684 B1 FR 3074684B1
Authority
FR
France
Prior art keywords
mass
exposure
blue light
new anti
stress process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1761824A
Other languages
French (fr)
Other versions
FR3074684A1 (en
Inventor
Virginie Anchartechahar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SERDEX SAS
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Original Assignee
SERDEX SAS
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SERDEX SAS, Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA filed Critical SERDEX SAS
Priority to FR1761824A priority Critical patent/FR3074684B1/en
Priority to EP18821722.8A priority patent/EP3720567A1/en
Priority to JP2020550919A priority patent/JP2021515028A/en
Priority to CN201880086107.9A priority patent/CN112105421A/en
Priority to PCT/FR2018/052967 priority patent/WO2019110887A1/en
Publication of FR3074684A1 publication Critical patent/FR3074684A1/en
Application granted granted Critical
Publication of FR3074684B1 publication Critical patent/FR3074684B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

Procédé dans le but d'empêcher ou de ralentir l'apparition des signes du vieillissement de la peau humaine ou des lèvres générés par le stress oxydatif provoqué par l'exposition à la lumière bleue, ou bien d'éliminer lesdits signes, comprenant au moins une étape d'application sur la peau humaine ou sur les lèvres, d'une formulation cosmétique à usage topique (Fi) comprenant pour 100% de sa masse : (1) - De 90% à 99,5% massique d'au moins un excipient cosmétiquement acceptable, et (2) - De 0,5% à 10% massique d'une composition (C1), comprenant pour 100% de sa masse : a) - De 90% à 99% massique d'au moins une composition (C2) comprenant pour 100% de sa propre masse : (i) - De 40% à 80% massique d'au moins un composé de formule (I) : HO-[CH2-CH(OH)-CH2-O-]nH (I), dans laquelle n représente un nombre entier supérieur ou égal à 1 et inférieur ou égal à 6, et (ii) - De 20% à 60% massique d'eau b) - De 1 % à 10 % massique, plus particulièrement de 1 % à 5% massique, et encore plus particulièrement de 1% à 3% massique d'un extrait (EX) de la plante d'espèce Hedy-chium coronarium.Process for the purpose of preventing or slowing the appearance of signs of aging of human skin or lips generated by oxidative stress caused by exposure to blue light, or else of eliminating said signs, comprising at least a step of applying to human skin or to the lips, a cosmetic formulation for topical use (Fi) comprising, for 100% of its mass: (1) - From 90% to 99.5% by mass of at least a cosmetically acceptable excipient, and (2) - From 0.5% to 10% by mass of a composition (C1), comprising, for 100% of its mass: a) - From 90% to 99% by mass of at least one composition (C2) comprising, for 100% of its own mass: (i) - From 40% to 80% by mass of at least one compound of formula (I): HO- [CH2-CH (OH) -CH2-O- ] nH (I), in which n represents an integer greater than or equal to 1 and less than or equal to 6, and (ii) - From 20% to 60% by mass of water b) - From 1% to 10% by mass , more particularly from 1% to 5% by mass, and even more particularly ement from 1% to 3% by mass of an extract (EX) of the plant of the species Hedy-chium coronarium.

FR1761824A 2017-12-08 2017-12-08 NEW ANTI-STRESS PROCESS FOR THE SKIN INDUCED BY EXPOSURE TO BLUE LIGHT Active FR3074684B1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR1761824A FR3074684B1 (en) 2017-12-08 2017-12-08 NEW ANTI-STRESS PROCESS FOR THE SKIN INDUCED BY EXPOSURE TO BLUE LIGHT
EP18821722.8A EP3720567A1 (en) 2017-12-08 2018-11-23 Novel method for reducing the effects of blue-light-induced stress on the skin
JP2020550919A JP2021515028A (en) 2017-12-08 2018-11-23 A new way to reduce the effects of blue light-induced stress on the skin
CN201880086107.9A CN112105421A (en) 2017-12-08 2018-11-23 Novel methods for mitigating the effects of blue light-induced stress on skin
PCT/FR2018/052967 WO2019110887A1 (en) 2017-12-08 2018-11-23 Novel method for reducing the effects of blue-light-induced stress on the skin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1761824 2017-12-08
FR1761824A FR3074684B1 (en) 2017-12-08 2017-12-08 NEW ANTI-STRESS PROCESS FOR THE SKIN INDUCED BY EXPOSURE TO BLUE LIGHT

Publications (2)

Publication Number Publication Date
FR3074684A1 FR3074684A1 (en) 2019-06-14
FR3074684B1 true FR3074684B1 (en) 2020-08-07

Family

ID=62067609

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1761824A Active FR3074684B1 (en) 2017-12-08 2017-12-08 NEW ANTI-STRESS PROCESS FOR THE SKIN INDUCED BY EXPOSURE TO BLUE LIGHT

Country Status (5)

Country Link
EP (1) EP3720567A1 (en)
JP (1) JP2021515028A (en)
CN (1) CN112105421A (en)
FR (1) FR3074684B1 (en)
WO (1) WO2019110887A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2022124120A1 (en) * 2020-12-11 2022-06-16
WO2022157544A1 (en) * 2021-01-22 2022-07-28 Jlwh Pte Ltd Compositions and methods for recovering from blue-light (bl) induced pigmentation, oxidative stress and inflammation
CN113101255A (en) * 2021-04-19 2021-07-13 广东梵蜜琳生物科技有限公司 Anti-premature composition and preparation method and application thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69915991T2 (en) * 1998-12-18 2005-03-10 Société d'Exploitation de Produits pour les Industries Chimiques S.E.P.P.I.C. Use in the cosmetics of a, against electrolytes, stable inverse latex
FR2787457B1 (en) * 1998-12-18 2004-12-17 Seppic Sa NEW INVERSE LATEX ELECTROLYTE STABLE, PREPARATION METHOD AND USE IN COSMETICS
US20020155138A1 (en) * 2001-01-19 2002-10-24 Martin Katharine M. Composition containing Hedychium extract and use thereof
WO2006053415A1 (en) 2004-11-18 2006-05-26 Biopharmacopae Design International Inc. Plant extract having matrix metalloprotease inhibiting activity and dermatological uses thereof
FR2895257A1 (en) 2005-12-22 2007-06-29 Oreal Use of lipophilic antioxidant as active principle for preparing cosmetic and/or dermatological composition to maintain and/or reinforce the protective and reparative native function of lipophilic structures of eye contour
FR2948285B1 (en) * 2009-07-27 2011-09-23 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic OIL-IN-WATER EMULSION WITH IMPROVED SENSORY PROPERTIES
BRPI0905586A8 (en) * 2009-12-21 2017-10-10 Antonio Meneghetti Ind E Com De Artigos De Vestuario Ltda COMPOSITION AND USE OF COSMETIC COMPOUNDS FOR DERMATOLOGICAL APPLICATION
KR20140101967A (en) * 2013-02-13 2014-08-21 한국임업진흥원 Eye serum comprising wood-cultivated ginseng extract and Manufacturinf method thereof
CN103494737B (en) * 2013-09-27 2015-04-22 浙江树人大学 Cosmetic preparation using ginger flower as anti-ageing and skin-protecting factor and preparation method of cosmetic preparation
FR3048881B1 (en) 2016-03-16 2020-03-27 Jafer Enterprises R&D, S.L. PEPTIDE AND OSIDIC HYDROLYSAT OF COCOA BEANS, COSMETIC COMPOSITIONS COMPRISING SAME AND THEIR COSMETIC USES
EP3342465A1 (en) * 2016-12-30 2018-07-04 Bayer Consumer Care AG Hedychium extract and compositions thereof and their use in the treatment of skin affected by harmful environmental influences

Also Published As

Publication number Publication date
CN112105421A (en) 2020-12-18
WO2019110887A1 (en) 2019-06-13
JP2021515028A (en) 2021-06-17
EP3720567A1 (en) 2020-10-14
FR3074684A1 (en) 2019-06-14

Similar Documents

Publication Publication Date Title
FR3074684B1 (en) NEW ANTI-STRESS PROCESS FOR THE SKIN INDUCED BY EXPOSURE TO BLUE LIGHT
EA202092003A1 (en) COMPOUNDS FOR TREATMENT OF GENTINGTON'S DISEASE
EA202092899A1 (en) HETEROARYL COMPOUNDS FOR THE TREATMENT OF GENTINGTON'S DISEASE
BR112015022096A8 (en) sodium channel modulating compounds, composition comprising them and use thereof
MX2017002451A (en) Compounds and methods for inhibiting histone demethylases.
BRPI0809164B8 (en) COMPOSITION FOR TOPICAL ADMINISTRATION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID COMPOSITION
ZA202201364B (en) Deuterated compounds for use in the treatment of cancer
EA202090068A1 (en) COMPOUNDS INFLUENCING PIGMENT SYNTHESIS AND THEIR APPLICATION FOR TREATMENT OF BACTERIAL DISEASES
BR112013003847A8 (en) methods of treating moderate cognitive impairment (mci) and related disorders
HRP20210323T1 (en) Sunscreen composition
RU2016146938A (en) COMPOSITIONS CONTAINING POLYMER SULFUR AND METHODS OF APPLICATION
SA519402556B1 (en) Cosmetic skincare compositions
MX2020004930A (en) Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors.
MX2021012353A (en) Topical cosmetic composition and uses thereof.
BR112023005226A2 (en) COMPOSITION TO PROMOTE THE SKIN MICROBIOME
BR112023000817A2 (en) ISOINDOLINE DERIVATIVE CONTAINING SULFUR, AND METHOD OF PREPARATION OF THE SAME AND MEDICAL USE OF THE SAME
CL2021000660A1 (en) Iron chelating compounds to treat aesthetic skin conditions
PH12020551117A1 (en) Compositions for preventing or treating uveitis
EA202090666A1 (en) APPLICATION OF BENZOATE-CONTAINING COMPOSITION FOR TREATMENT OF GLYCINE ENCEPHALOPATHY
EA202190766A1 (en) IMMUNOMODULATORS, THEIR COMPOSITIONS AND METHODS OF APPLICATION
BR112017010740A2 (en) ? compound, cosmetic composition, use and method for cosmetic treatment?
FR3067938B1 (en) USE OF A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION AGAINST THE EFFECTS INDUCED BY BLUE LIGHT
FR3074045B1 (en) COSMETIC COMPOSITION WITH CYSTOSEIRA TAMARISCIFOLIA ALGAE EXTRACT.
BR112015026484A2 (en) treatment or prevention of noninflammatory neuronal damage from brain trauma and strokes using menthol, linalool and / or icilin
MX354866B (en) Cosmetic or dermatological composition comprising a merocyanine and an insoluble organic uv-screening agent and/or an insoluble inorganic uv- screening agent.

Legal Events

Date Code Title Description
PLSC Publication of the preliminary search report

Effective date: 20190614

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7